Entelos Announces Expanded Collaboration With Johnson & Johnson Pharmaceutical Research & Development

20-Mar-2006

Entelos, Inc. announced that it has expanded its research collaboration with Johnson & Johnson Pharmaceutical Research & Development, L.L.C., (J&JPRD) to include multiple therapeutic areas over a five-year term. During the first year of this new agreement, Entelos will dedicate several teams of research engineers and life scientists to support specific projects using its PhysioLab® platforms on behalf of J&JPRD and its affiliates.

As previously reported, J&JPRD is already using Entelos models to validate targets, select biomarkers, and optimize clinical trials for type II diabetes, obesity, and anemia.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances